Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Scar tissue

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    62 result(s) found for: Scar tissue. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2008-002124-28 Sponsor Protocol Number: RN1001-0091 Start Date*: 2008-11-17
    Sponsor Name:Renovo Ltd
    Full Title: A double blind, within patient, placebo controlled trial to assess the efficacy of Juvista (avotermin) in conjunction with scar revision surgery for the improvement of disfiguring scars.
    Medical condition: Improvement of scar appearance
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039589 Scarring LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FR (Completed) HU (Completed) ES (Completed) DK (Completed) IT (Completed) DE (Completed) LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004938-24 Sponsor Protocol Number: RN1001-0098 Start Date*: 2009-03-24
    Sponsor Name:Renovo
    Full Title: A within patient, placebo controlled, proof of concept trial to assess the efficacy of Juvista in improving the appearance of existing scars that are 2-6 months old.
    Medical condition: Improvement of existing scars
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039589 Scarring LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-001455-11 Sponsor Protocol Number: RN1003-0027 Start Date*: 2006-04-03
    Sponsor Name:Renovo Ltd
    Full Title: A single centre, placebo and standard care controlled, double blind, randomised, trial to investigate the efficacy of eight doses of RN1003 in the reduction of scarring from approximated wound marg...
    Medical condition: Prevention and reduction of scarring
    Disease: Version SOC Term Classification Code Term Level
    6.1 10039580 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-003118-15 Sponsor Protocol Number: 97807 Start Date*: 2017-10-31
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: A double blind, placebo controlled, randomised dose escalation trial to investigate the safety and efficacy of topical salbutamol in the improvement of scar appearance when applied to approximated ...
    Medical condition: Improvement of (hypertrophic)scar appearance
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10020879 Hypertrophic scar PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-001362-32 Sponsor Protocol Number: Prot-06032007 Start Date*: 2008-03-03
    Sponsor Name:University Hospitals Of Leicester NHS Trust
    Full Title: The use of non-ionic contrast media to clear corneal scars
    Medical condition: Will plan to investigate patients who would benefit from cataract surgery but whom have corneal scarring which would make surgery difficult.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011044 Corneal scar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-003216-37 Sponsor Protocol Number: n.a. Start Date*: 2015-02-12
    Sponsor Name:
    Full Title: Efficacy of Verapamil/ Verapamil-Kenacort injection versus Kenacort injection in Scar Treatment
    Medical condition: Hypertrophic and keloid scars are pathological scars as a result of dermal injury and exhibit exuberant, indefinite growth of collagen during wound healing. Hypertrophic and keloid scars often caus...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-001889-17 Sponsor Protocol Number: MW2012-01-02 Start Date*: 2011-07-26
    Sponsor Name:MediWound, Ltd.
    Full Title: Scar Formation and Quality of Life assessment in subjects (adults & children) following treatment with Debrase compared to Standard of Care (SOC)
    Medical condition: long term scar formation
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10057061 Burn scar LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-022290-34 Sponsor Protocol Number: 10-001 Start Date*: 2010-12-07
    Sponsor Name:Pharmecosse
    Full Title: An investigation of the efficacy of a single dose of insulin in the prevention of excessive cutaneous scarring in breast surgery patients
    Medical condition: Scarring arising from non cancer-related bilateral breast surgery
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001979-38 Sponsor Protocol Number: MultiH/BRA/711 (incl. Amendment #2) Start Date*: 2007-01-15
    Sponsor Name:Bracco Imaging Deutschland GmbH
    Full Title: INTRAINDIVIDUAL CROSS-OVER STUDY TO COMPARE MULTIHANCE® AND OMNISCAN® AT A DOSE OF 0.1 MMOL/KGBW IN THE DIFFERENTIAL DIAGNOSIS OF DISC HERNIATION VS. SCAR
    Medical condition: Intervertebral disc herniation
    Disease: Version SOC Term Classification Code Term Level
    8.1 10048856 Intervertebral disc herniation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2016-004110-10 Sponsor Protocol Number: 2ABC Start Date*: 2017-12-21
    Sponsor Name:Medical University of Warsaw
    Full Title: Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The t...
    Medical condition: Scar or cutis laxa
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004863 10039581 Scar conditions and fibrosis of skin LLT
    20.0 10040785 - Skin and subcutaneous tissue disorders 10011692 Cutis laxa PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2011-004498-96 Sponsor Protocol Number: CHAD1030 Start Date*: 2011-11-25
    Sponsor Name:Moorfields Eye Hospital
    Full Title: Ozurdex in proliferative vitreoretinopathy; a randomised control trial
    Medical condition: Proliferative Vitreoretinopathy
    Disease: Version SOC Term Classification Code Term Level
    14.0 10015919 - Eye disorders 10038934 Retinopathy proliferative PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-002675-34 Sponsor Protocol Number: NL40235.078.12 Start Date*: 2012-09-12
    Sponsor Name:
    Full Title: Surgical and aesthetic outcome, quality of life, and cost-effectiveness of keloid treatment
    Medical condition: Keloid
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-003228-18 Sponsor Protocol Number: NL74548.078.20 Start Date*: 2021-05-25
    Sponsor Name:Erasmus MC
    Full Title: Intralesional bleomycin treatment of keloids using an electronic pneumatic jet injector: a double-blind randomized, placebo-controlled trial with split-lesion design
    Medical condition: Keloids
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002462-41 Sponsor Protocol Number: TBRU-dS-RAC-PII Start Date*: 2018-10-29
    Sponsor Name:CUTISS AG
    Full Title: A Phase II, prospective, intra-patient randomized controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the...
    Medical condition: Adults and children with full thickness skin defects
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2014-005656-26 Sponsor Protocol Number: 51748.094.15 Start Date*: 2015-10-14
    Sponsor Name:Westfriesgasthuis
    Full Title: Amitriptyline 10% and ketamine 10% cream in neuropathic pain: A randomised, double-blind, placebo-controlled cross-over pilot study with a three months open follow-up
    Medical condition: Patients with peripheral neuropathic pain or scar pain
    Disease: Version SOC Term Classification Code Term Level
    17.1 10040785 - Skin and subcutaneous tissue disorders 10049002 Scar pain PT
    17.1 100000004852 10029181 Nerve pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-006050-51 Sponsor Protocol Number: RD.06.SPR.202395 Start Date*: 2021-08-03
    Sponsor Name:Galderma S.A.
    Full Title: Evaluation of the risk of atrophic acne scar formation during treatment of acne vulgaris subjects with trifarotene 50 µg/g cream versus vehicle cream over 24 weeks
    Medical condition: acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2017-002460-41 Sponsor Protocol Number: TBRU-dS-BA-PIIb Start Date*: 2018-10-29
    Sponsor Name:CUTISS AG
    Full Title: A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for th...
    Medical condition: Adults and adolescents with partial deep dermal and full thickness burns
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2017-002461-21 Sponsor Protocol Number: TBRU-dS-BC-PIIb Start Date*: 2018-10-29
    Sponsor Name:CUTISS AG
    Full Title: A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for th...
    Medical condition: Children with partial deep dermal and full thickness burns
    Disease:
    Population Age: Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-000901-21 Sponsor Protocol Number: 2013.03 Start Date*: 2013-10-24
    Sponsor Name:Rode Kruis Ziekenhuis
    Full Title: A randomized clinical trial on the effectiveness, cost-effectiveness and quality of life of Flaminal® versus Flammazine® in the treatment of superficial and deep partial thickness burns
    Medical condition: Patients with partial thickness burns and/ or mixed depth of partial and full thickness burns
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004863 10015723 Extensive burns LLT
    14.1 100000004863 10006796 Burns eyes LLT
    14.1 100000004863 10006795 Burns extensive LLT
    16.0 100000004863 10006794 Burns classified according to extent of body surface involved LLT
    14.1 100000004863 10043441 Third degree burns LLT
    14.1 100000004863 10006801 Burns of multiple specified sites, unspecified degree LLT
    16.0 100000004863 10012087 Deep necrosis of underlying tissues due to burns (dtd) of multiple specified sites w/o mention lobp LLT
    14.1 100000004863 10028175 Multiple burns LLT
    14.1 100000004863 10039798 Second degree burns LLT
    16.0 100000004863 10031700 Other burns of eyelids and periocular area LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015166-62 Sponsor Protocol Number: EME-08/43/15 Start Date*: 2010-11-16
    Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust
    Full Title: A randomised controlled trial of Losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    Medical condition: Fibrosis in patients with non-alcoholic steatohepatitis.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10019805 - Hepatobiliary disorders 10053219 Non-alcoholic steatohepatitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 02 07:45:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA